SELLAS Life Sciences
SLS
SLS
24 hedge funds and large institutions have $1.99M invested in SELLAS Life Sciences in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $2.68M → $1.99M (-$690K)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
24
Holding in Top 10
–
Calls
$1.06M
Puts
$23K
Top Buyers
| 1 | +$102K | |
| 2 | +$13K | |
| 3 | +$10.4K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$10K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.53K |
Top Sellers
| 1 | -$63.3K | |
| 2 | -$24K | |
| 3 | -$20.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$18K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$16K |